Cencora Inc. (COR)

COR · Health Care · United States

Cencora Inc. (COR) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 1.08 % in XDEB (msci-world-minimum-volatility). Anyone holding one of these ETFs also owns a small indirect stake in Cencora.

Above-average ETF coverage: 20 of the 95 ETFs we cover hold Cencora, spread across 9 indices. That puts the stock in more ETFs than 82.9 % of the 4,334 stocks we cover.

Held in20 ETFs

Highest weight1.08 %

Indices9

SectorHealth Care

CountryUnited States

ISINUS03073E1055

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	-5.7 %	1 year	+9.8 %
1 month	+1.9 %	3 months	+14.9 %
Calendar year 2025	+50.3 %

52W

Data note 3

Measured in euros, Cencora returned -4.0 % year to date and +12.4 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-32.6 %

Volatility p.a.26.4 %

Data note 5

Below peak-15.0 %

Beta to S&P 500-0.17

Correlation to S&P 500-0.07

The close on Sep 16, 2026 was 15.0 % below the highest close since Aug 12, 2024, reached on Nov 25, 2025. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, Cencora moved on average 0.17 % in the opposite direction. The correlation of -0.07 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
McKesson Corporation	+0.75
Cardinal Health Inc.	+0.61
Erie Indemnity Company Class A	+0.54
Marsh & McLennan Companies Inc.	+0.54
Arch Capital Group Ltd.	+0.53
Arthur J. Gallagher & Co.	+0.52
Lumentum Holdings Inc.	-0.50
S&P 500 Informationstechnologie	-0.48
Western Digital Corporation	-0.48

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-09-30) as filed with the SEC.

Revenue321.3 bn $

Net income1.6 bn $

Diluted EPS7.96 $

Net margin0.5 %

Gross margin3.6 %

Return on equity81.4 %

Equity ratio2.4 %

Revenue growth+9.3 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	262.2	1.7	0.7 %
FY2024	294.0	1.5	0.5 %
FY2025	321.3	1.6	0.5 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XDEB	msci-world-minimum-volatility	1.08 %	€10.80
XUHL / XUHC	msci-usa-health-care	0.96 %	€9.60
XDWH	msci-world-health-care	0.71 %	€7.10
SPFS	msci-world-health-care	0.71 %	€7.10
SPYL / SPY5	sp500	0.10 %	€1.00
SXR8	sp500	0.10 %	€1.00
XD9U / XD9D	msci-usa	0.09 %	€0.90
EUNL	msci-world	0.07 %	€0.70
XDWD / XDWL	msci-world	0.07 %	€0.70
SWWD	msci-world	0.06 %	€0.60
WIMI	msci-world-imi	0.06 %	€0.60
SPYY	msci-acwi	0.06 %	€0.60
IUSQ	msci-acwi	0.06 %	€0.60
SPPW	msci-world	0.06 %	€0.60
SPYI / SPSA	msci-acwi-imi	0.02 %	€0.20

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Cencora as of the fund's latest holdings list.

Weight in EUNL since 2023

Sep 29, 2023Sep 16, 2026

In EUNL, a fund tracking the MSCI World, Cencora had a weight of 0.06 % on Sep 29, 2023 and 0.07 % on Sep 16, 2026. Its share peaked at 0.07 % on Mar 31, 2025. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much Cencora Inc. overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Cencora — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Cencora	+9.8 %	26.4 %	0.5 %	+9.3 %
AbbVie	+21.4 %	26.9 %	6.9 %	+8.6 %
Abbott Laboratories	-22.9 %	24.1 %	14.7 %	+5.7 %
Cardinal Health	+56.7 %	26.4 %	0.7 %	-1.9 %
McKesson Corporation	+28.0 %	28.6 %	1.2 %	+12.4 %
Edwards Lifesciences Corporation	+18.9 %	25.1 %	17.7 %	+11.5 %
HCA Healthcare Inc	+7.7 %	29.1 %	9.0 %	+7.1 %
Eli Lilly and Company	+48.8 %	38.3 %	31.7 %	+44.7 %
Boston Scientific Corporation	-55.6 %	31.0 %	–	+19.9 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.